Suppr超能文献

进行性多灶性白质脑病:流行病学及易感状况谱

Progressive multifocal leukoencephalopathy: epidemiology and spectrum of predisposing conditions.

作者信息

Joly Marine, Conte Cécile, Cazanave Charles, Le Moing Vincent, Tattevin Pierre, Delobel Pierre, Sommet Agnès, Martin-Blondel Guillaume

机构信息

Department of Infectious and Tropical Diseases, Toulouse University Hospital Center, Toulouse 31300, France.

Department of Medical Pharmacology, CIC 1436, Toulouse University Hospital Center, Toulouse 31300, France.

出版信息

Brain. 2023 Jan 5;146(1):349-358. doi: 10.1093/brain/awac237.

Abstract

Population-based data on the epidemiology of progressive multifocal leukoencephalopathy, its predisposing conditions and mortality rate are lacking, although such data are crucial to raise awareness among clinicians and to lay foundations for future therapeutic trials in immunomodulating therapies. In our study, patients were identified by interrogating the French national healthcare reimbursement database from 1 January 2008 to 31 December 2017, using progressive multifocal leukoencephalopathy International Classification of Diseases code and a patient's selection algorithm. Overall incidence rate, 1-year all-cause mortality rate and survival patterns were calculated, and factors associated with death were identified using a multivariate Cox proportional hazards regression model. Our cohort is the largest to date, comprising 584 patients with incident progressive multifocal leukoencephalopathy. The overall incidence in France from 2010 to 2017 was stable during the study period at 0.11 per 100 000 person-years, 95% confidence interval [0.10-0.12]. Predisposing diseases were HIV infection (43.7%), followed by haematological malignancies (21.9%), chronic inflammatory diseases (20.2%), solid organ transplantation (4.3%), solid neoplasm (4.1%) and primary immune deficiency (1.5%). The 1-year mortality rate was 38.2%, with a 95% confidence interval (34.2-42.2). In multivariate analysis, factors independently associated with death were older age [adjusted hazard ratio 0.33 (0.20-0.53) for patients aged 20 to 40 compared with patients aged over 60], male gender [adjusted hazard ratio 0.73 (0.54-0.99) for females compared with males] and predisposing immunosuppressive disease, with the highest risk for solid neoplasms [adjusted hazard ratio 4.34 (2.25-8.37)], followed by haematological malignancies [adjusted hazard ratio 3.13 (1.85-5.30)] and HIV infection [adjusted hazard ratio 1.83 (1.12-3.00)], compared with chronic inflammatory diseases. Immune reconstitution inflammatory syndrome was notified in 7.0% of patients. In conclusion, incidence of progressive multifocal leukoencephalopathy is stable in France, and HIV infection remains the main predisposing disease. This large-size cohort uncovers a higher risk of mortality for male patients compared to females, and the worst prognosis for patients with solid neoplasm, while prognosis in patients with haematological malignancies appeared less dismal than in previous studies.

摘要

尽管基于人群的进行性多灶性白质脑病流行病学、其诱发因素和死亡率数据对于提高临床医生的认识以及为未来免疫调节治疗的临床试验奠定基础至关重要,但目前仍很缺乏。在我们的研究中,通过查询2008年1月1日至2017年12月31日的法国国家医疗保健报销数据库,使用进行性多灶性白质脑病国际疾病分类代码和患者选择算法来识别患者。计算总体发病率、1年全因死亡率和生存模式,并使用多变量Cox比例风险回归模型确定与死亡相关的因素。我们的队列是迄今为止最大的,包括584例新发进行性多灶性白质脑病患者。2010年至2017年法国的总体发病率在研究期间保持稳定,为每10万人年0.11例,95%置信区间为[0.10 - 0.12]。诱发疾病为HIV感染(43.7%),其次是血液系统恶性肿瘤(21.9%)、慢性炎症性疾病(20.2%)、实体器官移植(4.3%)、实体瘤(4.1%)和原发性免疫缺陷(1.5%)。1年死亡率为38.2%,95%置信区间为(34.2 - 42.2)。在多变量分析中,与死亡独立相关的因素包括年龄较大[20至40岁患者与60岁以上患者相比,调整后风险比为0.33(0.20 - 0.53)]、男性[女性与男性相比,调整后风险比为0.73(0.54 - 0.99)]以及诱发免疫抑制性疾病,实体瘤风险最高[调整后风险比为4.34(2.25 - 8.37)],其次是血液系统恶性肿瘤[调整后风险比为3.13(1.85 - 5.30)]和HIV感染[与慢性炎症性疾病相比,调整后风险比为1.83(1.12 - 3.00)]。7.0%的患者出现免疫重建炎症综合征。总之,法国进行性多灶性白质脑病的发病率稳定,HIV感染仍然是主要的诱发疾病。这个大型队列发现男性患者的死亡风险高于女性,实体瘤患者的预后最差,而血液系统恶性肿瘤患者的预后似乎比以前的研究要好。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验